Post by
dmacd on Jan 12, 2022 10:07am
Compelling despite Headwinds
$90M cash vs $128M MC. Way too low for a company this advanced. FDA caused job losses in US with their approach. Would be nice to get some clarity on the issue but the reorg suggests it will take time.